| Market Capitalization (Millions $) |
2,253 |
| Shares
Outstanding (Millions) |
240 |
| Employees |
647 |
| Revenues (TTM) (Millions $) |
508 |
| Net Income (TTM) (Millions $) |
165 |
| Cash Flow (TTM) (Millions $) |
40 |
| Capital Exp. (TTM) (Millions $) |
19 |
Business Description
Adma Biologics Inc.
is a publicly traded biopharmaceutical company based in New Jersey, United States.
It is primarily focused on the development and commercialization of plasma-based biologics for the treatment of a variety of infectious diseases and disorders.
Adma Biologics was founded in 2004 and has since then become a leader in the plasma-derived therapeutics field.
The company has developed and marketed a number of FDA-approved intravenous immunoglobulin (IVIG) products for the treatment of primary humoral immunodeficiency disease.
IVIG products manufactured by Adma Biologics are derived from human plasma collected from a variety of qualified sources in the US, and are purified and treated to remove any viral, bacterial, or other contaminants that could compromise the productes safety and efficacy.
In addition to IVIG products, Adma Biologics has also developed Bivigame and Nabi-HBe for the treatment of Hepatitis B and C in specific patient populations.
The company is also developing products for the treatment of pneumococcal and other bacterial infections.
The companyes proprietary technology, called RI-002, enables the production of highly concentrated, pure polyclonal human immunoglobulin G (IgG) for the treatment and prevention of a wide range of viral and bacterial infections.
The technology has the potential to revolutionize the production of high-quality, pure biologic products that are safe and effective for human use.
Overall, Adma Biologics is dedicated to improving the lives of patients with serious and life-threatening medical conditions by developing innovative therapies that address unmet medical needs.
The company's research and development efforts are focused on creating new treatments for infectious diseases, autoimmune disorders, and other serious medical conditions, with the goal of providing safe and effective therapies that can improve the overall quality of life for patients.
Company Address: 465 State Route 17 Ramsey 7446 NJ
Company Phone Number: 478-5552 Stock Exchange / Ticker: NASDAQ ADMA
|
17.76% 
100.62 %